Cadrenal Therapeutics Inc Share Price Today: Live Updates & Key Insights
Cadrenal Therapeutics Inc share price today is $2.01, up 0.49%. The stock opened at $2.0476 against the previous close of $2.03, with an intraday high of $2.16 and low of $1.92.
Cadrenal Therapeutics Inc Share Price Chart
Cadrenal Therapeutics Inc
Cadrenal Therapeutics Inc Share Price Performance
Cadrenal Therapeutics Inc Institutional Holdings
Cadrenal Therapeutics Inc Market Status
Cadrenal Therapeutics Inc Fundamentals
Market Cap 6.29 M
PB Ratio 3.6208
PE Ratio 0.0
Enterprise Value 2.15 M
Total Assets 4.33 M
Volume 80260
Cadrenal Therapeutics Inc Company Financials
About Cadrenal Therapeutics Inc & investment objective
Company Information Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions. The company is developing Tecarfarin, an oral vitamin K antagonist that is in Phase 3 clinical trial designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, and atrial fibrillation; CAD-1005, a first-in-class 12-LOX inhibitor for the treatment of heparin-induced thrombocytopenia, a deadly immune-mediated thrombotic disorder that has completed Phase 2 clinical trial; and Frunexian, a parenteral clinical-stage factor XIa inhibitor designed for use in acute hospital settings that has completed Phase 1 clinical trial. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
Organisation Biotechnology
Employees 5
Industry Biotechnology
CEO Mr. Quang X. Pham
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Cadrenal Therapeutics Inc FAQs
What is the share price of Cadrenal Therapeutics Inc today?
The current share price of Cadrenal Therapeutics Inc is $2.01.
Can I buy Cadrenal Therapeutics Inc shares in India?
Yes, Indian investors can buy Cadrenal Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Cadrenal Therapeutics Inc shares in India?
You can easily invest in Cadrenal Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Cadrenal Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Cadrenal Therapeutics Inc.
Can I buy fractional shares of Cadrenal Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Cadrenal Therapeutics Inc?
Cadrenal Therapeutics Inc has a market cap of $6.29 M.
In which sector does Cadrenal Therapeutics Inc belong?
Cadrenal Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Cadrenal Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Cadrenal Therapeutics Inc?
The PE ratio of Cadrenal Therapeutics Inc is N/A and the PB ratio is 3.62.